ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89 | -15.2% | 28,284 | +33.6% | 0.00% | 0.0% |
| Q2 2023 | $105 | +18.0% | 21,175 | +16.9% | 0.00% | 0.0% |
| Q1 2023 | $89 | +7.2% | 18,110 | +37.0% | 0.00% | 0.0% |
| Q4 2022 | $83 | -100.0% | 13,220 | -23.5% | 0.00% | -60.0% |
| Q3 2022 | $186,000 | +195.2% | 17,272 | +211.8% | 0.01% | +150.0% |
| Q2 2022 | $63,000 | -4.5% | 5,540 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $66,000 | -20.5% | 7,276 | +123.5% | 0.00% | 0.0% |
| Q3 2021 | $83,000 | 0.0% | 3,255 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $83,000 | -25.9% | 3,220 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $112,000 | +38.3% | 3,180 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $81,000 | +84.1% | 3,240 | +172.7% | 0.00% | 0.0% |
| Q3 2020 | $44,000 | – | 1,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |